Changes in P-gp function are associated with several neurodegenerative and psychiatric diseases, including Alzheimer’s disease, Parkinson’s disease and schizophrenia and with the bioavailability of several pharmaceuticals in the brain, causing multi-drug resistance or side effects. This evidence concerns the gene PGP and psychiatric disorder.